These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17297410)

  • 21. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.
    Grimbert P; Audard V; Diet C; Matignon M; Plonquet A; Mansour H; Desvaux D; Durrbach A; Cohen JL; Lang P
    Nephrol Dial Transplant; 2011 Mar; 26(3):1087-93. PubMed ID: 20667993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation.
    Iwase H; Kobayashi T; Kodera Y; Miwa Y; Kuzuya T; Iwasaki K; Haneda M; Katayama A; Takeda A; Morozumi K; Watarai Y; Uchida K; Nakao A
    Transplantation; 2011 Jan; 91(2):191-8. PubMed ID: 21157405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome.
    Yapici U; Bemelman FJ; Scheepstra CG; Roelofs JJ; Claessen N; van der Loos C; van Donselaar-van der Pant K; Bouts AH; Idu MM; Rowshani AT; ten Berge IJ; Florquin S
    Transplantation; 2009 May; 87(9):1377-80. PubMed ID: 19424039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foxp3 staining in BK virus allograft nephropathy and comparison with acute cellular rejection.
    Miller DC; Qazi Y; Smogorzewski M; Azen CG; Shah T; Koss MN
    Transplant Proc; 2009 Dec; 41(10):4188-92. PubMed ID: 20005366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does borderline kidney allograft rejection always require treatment?
    Németh D; Ovens J; Opelz G; Sommerer C; Döhler B; Becker LE; Gross ML; Waldherr R; Mieth M; Sadeghi M; Schmidt J; Langer RM; Zeier M; Süsal C
    Transplantation; 2010 Aug; 90(4):427-32. PubMed ID: 20622754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.
    Louis S; Braudeau C; Giral M; Dupont A; Moizant F; Robillard N; Moreau A; Soulillou JP; Brouard S
    Transplantation; 2006 Feb; 81(3):398-407. PubMed ID: 16477227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection.
    Yannaraki M; Rebibou JM; Ducloux D; Saas P; Duperrier A; Felix S; Rifle G; Chalopin JM; Hervé P; Tiberghien P; Ferrand C
    Transpl Int; 2006 Sep; 19(9):759-68. PubMed ID: 16918537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxp3 as a marker of tolerance induction versus rejection.
    Zhang GY; Hu M; Wang YM; Alexander SI
    Curr Opin Organ Transplant; 2009 Feb; 14(1):40-5. PubMed ID: 19337145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.
    Li Y; Zhao X; Cheng D; Haga H; Tsuruyama T; Wood K; Sakaguchi S; Tanaka K; Uemoto S; Koshiba T
    Transplantation; 2008 Dec; 86(12):1837-43. PubMed ID: 19104431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues.
    Graziotto R; Del Prete D; Rigotti P; Anglani F; Baldan N; Furian L; Valente M; Antonello A; Marchini F; D'Angelo A; Gambaro G
    Transplantation; 2006 Apr; 81(8):1125-32. PubMed ID: 16641597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation.
    Eljaafari A; Badet L; Kanitakis J; Ferrand C; Farre A; Petruzzo P; Morelon E; Dubosson M; Tiberghien P; Dubois V; Martin X; Miossec P; Dubernard JM
    Transplantation; 2006 Dec; 82(12):1764-8. PubMed ID: 17198273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
    Kelley TW; Pohlman B; Elson P; Hsi ED
    Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts.
    Carstens J; Markussen N; Madsen M
    Transplant Proc; 2005 Oct; 37(8):3294-7. PubMed ID: 16298578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection.
    Kummer JA; Wever PC; Kamp AM; ten Berge IJ; Hack CE; Weening JJ
    Kidney Int; 1995 Jan; 47(1):70-7. PubMed ID: 7731173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
    Krustrup D; Madsen CB; Iversen M; Engelholm L; Ryder LP; Andersen CB
    Transpl Immunol; 2013 Dec; 29(1-4):71-5. PubMed ID: 23969200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
    Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
    Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ expression of mononuclear cell markers and interleukin-2 receptor in renal allograft biopsies of acute rejection and borderline cases.
    Rodrigues FM; de Carvalho MF; Franchi MR; Gandin CM; Viero RM
    Ren Fail; 2007; 29(1):29-35. PubMed ID: 17365907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients.
    Dijke IE; Caliskan K; Korevaar SS; Maat AP; Zondervan PE; Balk AH; Weimar W; Baan CC
    Transpl Immunol; 2008 Jan; 18(3):250-4. PubMed ID: 18047933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis.
    Zuber J; Brodin-Sartorius A; Lapidus N; Patey N; Tosolini M; Candon S; Rabant M; Snanoudj R; Panterne C; Thervet E; Legendre C; Chatenoud L
    Nephrol Dial Transplant; 2009 Dec; 24(12):3847-54. PubMed ID: 19729462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary FOXP3 messenger RNA and renal-allograft rejection.
    Strehlau J; Podolskaya A; Ehrich J
    N Engl J Med; 2006 May; 354(21):2291-3; author reply 2291-3. PubMed ID: 16729371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.